Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study-Reference-Cited by-同舟云学术

Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study

Published:2023-08-09 Issue:4 Volume:26 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Georgakopoulou Vasiliki¹,Gkoufa Aikaterini¹,Makrodimitri Sotiria¹,Basoulis Dimitrios¹,Tsakanikas Aristeidis¹,Karamanakos Georgios¹,Mastrogianni Elpida²,Voutsinas Pantazis³,Spandidos Demetrios⁴,Papageorgiou Chrysovalantis²,Gamaletsou Maria³,Sipsas Nikolaos¹

Affiliation:

1. Department of Infectious Diseases and COVID‑19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

2. Emergency Department, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

3. Department of Pathophysiology, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

4. Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference31 articles.

1. Safety and efficacy of outpatient treatments for COVID-19: Real-life data from a regionwide cohort of high-risk patients in Tuscany, Italy (the FEDERATE cohort);Manciulli;Viruses,2023

2. Remdesivir treatment in moderately Ill COVID-19 patients: A retrospective single center study;Terkes;J Clin Med,2022

3. Remdesivir and its antiviral activity against COVID-19: A systematic review;Frediansyah;Clin Epidemiol Glob Health,2021

4. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir;Liang;Eur J Med Chem,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment of COVID-19: lessons learned and future directions;Future Virology;2024-08-12

2. Personalized Assessment of Mortality Risk and Hospital Stay Duration in Hospitalized Patients with COVID-19 Treated with Remdesivir: A Machine Learning Approach;Journal of Clinical Medicine;2024-03-22

3. The parallel lives of pandemics: COVID‑19 and obesity;Experimental and Therapeutic Medicine;2024-03-06

4. A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review);International Journal of Molecular Medicine;2024-01-26

5. Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study;Therapeutic Advances in Infectious Disease;2024-01